Production (Stage)
Rani Therapeutics Holdings, Inc.
RANI
$0.557
-$0.0022-0.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 172.00K | 1.03M | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 172.00K | 1.03M | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 172.00K | 1.03M | -- | -- | -- |
| SG&A Expenses | 5.62M | 5.46M | 5.63M | 6.41M | 6.45M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.19M | 12.27M | 11.80M | 12.52M | 14.03M |
| Operating Income | -12.01M | -11.24M | -11.80M | -12.52M | -14.03M |
| Income Before Tax | -12.74M | -15.72M | -12.72M | -13.36M | -14.78M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.74M | -15.72M | -12.72M | -13.36M | -14.78M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 5.47M | 6.78M | 5.94M | 6.56M | 7.30M |
| Net Income | -7.26M | -8.95M | -6.78M | -6.81M | -7.48M |
| EBIT | -12.01M | -11.24M | -11.80M | -12.52M | -14.03M |
| EBITDA | -11.76M | -10.98M | -11.54M | -12.27M | -13.79M |
| EPS Basic | -0.22 | -0.27 | -0.24 | -0.26 | -0.29 |
| Normalized Basic EPS | -0.07 | -0.02 | -0.07 | -0.07 | -0.07 |
| EPS Diluted | -0.22 | -0.27 | -0.24 | -0.26 | -0.29 |
| Normalized Diluted EPS | -0.07 | -0.02 | -0.07 | -0.07 | -0.07 |
| Average Basic Shares Outstanding | 33.44M | 32.66M | 28.84M | 26.32M | 26.03M |
| Average Diluted Shares Outstanding | 33.44M | 32.66M | 28.84M | 26.32M | 26.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |